Stockhub

Bone Therapeutics SA: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

21 August 2022

  • curprev 23:0323:03, 21 August 2022 >Nick 626 bytes +626 Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == Bone Therapeutics SA, a biotechnology company, engages in the development of cell therapy products for orthopedics and bone diseases. Its products include ALLOB, an allogeneic cell therapy product, which is in Phase I/IIa clinical trial for the treatment of delayed-union fractures and lumbar spinal fusion; and JTA-004, an intra-articular injectable that is in phase III clinical trial to treat osteoarthritic pain in the knee..."
Retrieved from "https://stockhub.co/research/Bone_Therapeutics_SA"